Antagonistic effect of Lepidium meyenii (red maca) on prostatic hyperplasia in adult mice

Andrologia

Volumn 40, Issue 3, 2008, Pages 179-185

  Gonzales, G F ^a   Gasco, M ^a   Malheiros Pereira, A ^a   Gonzales Castaneda C ^a  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Lepidium meyenii; Mice; Prostatic hyperplasia; Prostatic stroma; Red maca; Ventral prostate

Indexed keywords

ESTRADIOL; FINASTERIDE; LEPIDIUM MEYENII EXTRACT; TESTOSTERONE; TESTOSTERONE ENANTATE;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; EPIDIDYMIS; ESTRADIOL BLOOD LEVEL; HISTOPATHOLOGY; LEPIDIUM; MOUSE; NONHUMAN; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; SEMINAL VESICLE; STROMA; TESTIS; TESTIS WEIGHT; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; ENZYME INHIBITORS; ESTRADIOL; FINASTERIDE; LEPIDIUM; MALE; MICE; PHYTOTHERAPY; PROSTATIC HYPERPLASIA; TESTOSTERONE;

EID: 43549112055     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2008.00834.x     Document Type: Article

References (22)

1. Babinski MA, Chagas MA, Costa WS, Sampaio FJ (2003) Prostatic epithelial and luminal area in the transition zone acini: morphometric analysis in normal and hyperplastic human prostate. BJU Int 92 : 592 596.
2. Dini I, Tenore GC, Dini A (2002) Glucosinolates from Maca (Lepidium meyenii). Biochem Syst Ecol 30 : 1087 1090.
3. Gasco M, Villegas L, Yucra S, Rubio J, Gonzales GF (2007) Effect dose-response of red maca on benign prostate hyperplasia in male rats. Phytomedicine 14 : 460 464.
4. Gonzales GF, Miranda S, Nieto J, Fernandez G, Yucra S, Rubio J, Yi P, Gasco M (2005) Red maca (Lepidium meyenii) reduced prostate size in rats. Reprod Biol Endocrinol 3 : 5.
5. Gonzales GF, Vasquez V, Rodriguez D, Maldonado C, Mormontoy J, Portella J, Pajuelo M, Villegas L, Gasco M (2007) Effect of two different extracts of red maca in male rats with testosterone-induced prostatic hyperplasia. Asian J Androl 9 : 245 251.
6. Henning SM, Aronson W, Niu Y, Conde F, Lee NH, Seeram NP, Lee RP, Lu J, Harris DM, Moro A, Hong J, Pak-Shan L, Barnard RJ, Ziaee HG, Csathy G, Go VL, Wang H, Heber D (2006) Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr 136 : 1839 1843.
7. Hiipakka RA, Zhang HZ, Dai W, Dai Q, Liao S (2002) Structure-activity relationships for inhibition of human 5 alpha-reductases by polyphenols. Biochem Pharmacol 63 : 1165 1176.
8. Le HT, Schaldach CM, Firestone GL, Bjeldanes LF (2003) Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem 278 : 21136 21145.
9. Li G, Ammermann U, Quiros CF (2001) Glucosinolate contents in maca (Lepidium peruvianum Chacon) seeds, sprouts, mature plants and several derived commercial products. Econ Bot 55 : 255 262.
10. Lin VK, Wang SY, Vasquez DV, Xu C, Zhang S, Tang L (2007) Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property. Prostate 67 : 1265 1276.
11. Marberger M, Harkaway R, de la Rosette J (2004) Optimising the medical management of benign prostatic hyperplasia. Eur Urol 45 : 411 419.
12. Martinez Caballero S, Carricajo Fernandez C, Perez-Fernandez R (2004) Effect of an integral suspension of Lepidium latifolium on prostate hyperplasia in rats. Fitoterapia 75 : 187 191.
13. Montironi R, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M (2007) Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nat Clin Pract Urol 4 : 321 332.
14. National Research Council (1996) Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington DC : p. 125.
15. Nishino T, Wedel T, Schmitt O, Buhlmeyer K, Schonfelder M, Hirtreiter C, Schulz T, Kuhnel W, Michna H (2004) Androgen-dependent morphology of prostates and seminal vesicles in the Hershberger assay: evaluation of immunohistochemical and morphometric parameters. Ann Anat 186 : 247 253.
16. O'Leary MP (2000) LUTS, ED, QOL: alphabet soup or real concerns to aging men? Urology 56 : 7 11.
17. Piacente S, Carbone V, Plaza A, Zampelli A, Pizza C (2002) Investigation of the tuber constituents of maca (Lepidium meyenii Walp). J Agric Food Chem 50 : 5621 5625.
18. Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH, Castellanos R, Coffield S, Saltzman B, Resnick M, Cook TJ, Waldstreicher J (1999) Serum prostate specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology 53 : 473 480.
19. Talalay P, Fahey JW (2001) Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 131 : 3027S 3033S.
20. Tsujimura A, Koikawa Y, Salm S, Takao T, Coetzee S, Moscatelli D, Shapiro E, Lepor H, Sun TT, Wilson L (2002) Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol 157 : 1257 1265.
21. Vaughan E (2003) Medical management of benign prostatic hyperplasia - are two drugs better than one N Engl J Med 349 : 2449 2451.
22. Ziada A, Rosenblum M, Crawford ED (1999) Benign prostatic hyperplasia: an overview. Urology 53 : 1 6.